检查神秘经验作为治疗耐药抑郁症psilocybin辅助心理治疗的预测因素
Ryan M Brudner1,2, Erica Kaczmarek3, Marc G Blainey4
1Mood Disorder Psychopharmacology Unit, UHN, Toronto, ON, Canada.
Journal of psychopharmacology (Oxford, England)
|July 1, 2025
概括
在第一剂psilocybin期间的神秘体验预测治疗耐药抑郁症患者的抗抑郁药效果更大. 神秘体验和治疗结果之间的这种联系在随后的剂量中没有观察到.
科学领域:
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
- 心理学 心理学 心理学
背景情况:
- 松素辅助心理治疗 (PAP) 在治疗精神疾病方面表现有前途,但其机制尚不清楚.
- 神秘体验是psilocybin的一个关键主观效应.
- 研究表明神秘体验可能预测积极的PAP结果.
研究的目的:
- 为了研究神秘经验作为抗抑郁药的预测结果在PAP.
- 在临床样本中检查这种关系与耐治疗抑郁症.
主要方法:
- 31名患有耐治疗重度抑郁症 (MDD) 或双极性II型障碍 (BDII) 的参与者接受了1-3次PAP治疗 (25毫克psilocybin).
- 抑郁症状在基线,剂前和剂后2周被评估.
- 神秘体验是在急性效应在服用日消失后被测量出来的.
主要成果:
- 在第一剂psilocybin服用后,更强烈的神秘体验与更强烈的抗抑郁药效应相关.
- 神秘体验与抗抑郁药效果之间的这种关联在第二次或第三次剂量中没有显著意义.
结论:
- 初步发现支持PAP的神秘体验的治疗重要性.
- 这项研究扩展了先前的研究,将其扩展到耐治疗的MDD和BDII群体.
相关概念视频
The Placebo Effect
6.3K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.3K
CNS Stimulants: Psychedelic Agents
254
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
254
Interpersonal Psychotherapy
101
Interpersonal psychotherapy (IPT) is a structured, time-limited therapeutic approach initially developed to treat depression. It integrates key concepts from psychodynamic, humanistic, and cognitive-behavioral therapies, making it a uniquely eclectic framework. The therapy is rooted in the interpersonal theories of Adolph Meyer and Harry Stack Sullivan, as well as John Bowlby's attachment theory, and focuses on the interplay between interpersonal relationships and emotional well-being.
101
Psychodynamic Therapy
151
Psychodynamic therapies emphasize the exploration of unconscious processes and early childhood experiences as fundamental contributors to psychological difficulties. These therapies, deeply rooted in Freud's psychoanalytic theory, aim to uncover and resolve unconscious conflicts, granting individuals insights that promote emotional and behavioral healing. Contemporary psychodynamic approaches have evolved, integrating a broader range of influences and methodologies while still valuing the...
151
Electroconvulsive Therapy
203
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
203
Hallucinogens and Psychedelics
291
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
291


